PNC Financial Services Group
RYTM icon

PNC Financial Services Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

PNC Financial Services Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$850K Buy
7,657
+719
+10% +$65K ﹤0.01% 1480
2026
Q1 		$603K Buy
6,938
+2,279
+49% +$222K ﹤0.01% 1554
2025
Q4 		$499K Buy
4,659
+442
+10% +$46.9K ﹤0.01% 1661
2025
Q3 		$426K Sell
4,217
-1,326
-24% -$123K ﹤0.01% 1764
2025
Q2 		$350K Buy
5,543
+1,025
+23% +$62.8K ﹤0.01% 1811
2025
Q1 		$239K Buy
4,518
+4,214
+1,386% +$234K ﹤0.01% 2051
2024
Q4 		$17K Buy
304
+181
+147% +$10K ﹤0.01% 3608
2024
Q3 		$6.44K Buy
123
+31
+34% +$1.49K ﹤0.01% 3963
2024
Q2 		$3.78K Sell
92
-9
-9% -$359 ﹤0.01% 4078
2024
Q1 		$4.38K Buy
+101
New +$4.42K ﹤0.01% 3996
2023
Q2 		– Sell
-350
Closed -$6.24K – 4819
2023
Q1 		$6.24K Hold
350
– – ﹤0.01% 3967
2022
Q4 		$10.2K Hold
350
– – ﹤0.01% 3772
2022
Q3 		$9K Hold
350
– – ﹤0.01% 3811
2022
Q2 		$1K Hold
350
– – ﹤0.01% 4373
2022
Q1 		$4K Hold
350
– – ﹤0.01% 4068
2021
Q4 		$3K Hold
350
– – ﹤0.01% 4086
2021
Q3 		$5K Sell
350
-9
-3% -$137 ﹤0.01% 3949
2021
Q2 		$7K Hold
359
– – ﹤0.01% 3802
2021
Q1 		$8K Hold
359
– – ﹤0.01% 3714
2020
Q4 		$11K Hold
359
– – ﹤0.01% 3542
2020
Q3 		$8K Buy
+359
New +$8.23K ﹤0.01% 3585

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PNC Financial Services Group's RYTM Position: Q2 2026 in Review

PNC Financial Services Group increased its Rhythm Pharmaceuticals (RYTM) stake by 10% in Q2 2026, buying an estimated $65K and bringing the position to 7,657 shares worth $850K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

PNC Financial Services Group first reported a position in RYTM in Q3 2020 and has held it in 21 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • PNC Financial Services Group held 7,657 shares of Rhythm Pharmaceuticals worth $850K as of Q2 2026.
  • PNC Financial Services Group bought 719 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $65K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1480 holding.
  • PNC Financial Services Group first reported a position in Rhythm Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.